Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002513738 | SCV003523519 | pathogenic | Charcot-Marie-Tooth disease type 2 | 2022-09-27 | criteria provided, single submitter | clinical testing | This variant, c.1368_1370del, results in the deletion of 1 amino acid(s) of the LMNA protein (p.Asn456del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with autosomal dominant LMNA-related conditions (PMID: 17377071, 22326558; Invitae). This variant disrupts a region of the LMNA protein in which other variant(s) (p.Asn456Lys) have been determined to be pathogenic (PMID: 18551513, 21520333, 22071332). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Epithelial Biology; Institute of Medical Biology, |
RCV000057280 | SCV000088393 | not provided | not provided | no assertion provided | not provided |